Merella Pierluigi, Talanas Giuseppe, İsgender Mehriban, Micheluzzi Valentina, Atzori Enrico, Bilotta Ferruccio, Wanha Wojciech, Bandino Stefano, Grzelakowska Klaudyna, Petretto Gerardo, Kubica Jacek, Wojakowski Wojciech, Casu Gavino, Navarese Eliano P
Clinical and Experimental Cardiology, Clinical and Interventional Cardiology, University of Sassari, Sassari, Italy.
SIRIO MEDICINE Research Network, Sassari, Italy.
ESC Heart Fail. 2024 Dec;11(6):4038-4045. doi: 10.1002/ehf2.14936. Epub 2024 Aug 5.
A paucity of studies addressed sex-related differences in clinical outcomes in the long term following acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI). In these patients, it remains uncertain whether heart failure (HF) might exert a differential impact on the prognosis in the long term.
We queried a large-scale database of ACS patients undergoing PCI. The primary endpoint was new-onset HF. Secondary endpoints included mortality, myocardial infarction, re-PCI and ischaemic stroke. Propensity score matching was generated to balance group characteristics. A total of 3334 patients after propensity score matching were analysed. Follow-up was assessed at the 5 year term.
At 5 year follow-up, HF risk increased significantly in males versus females {17.9% vs. 14.8%, hazard ratio [HR] [95% confidence interval (CI)] = 1.22 [1.03-1.44], P = 0.02}. At 5 year follow-up, mortality was significantly higher in the male cohort as compared with the female cohort [HR (95% CI) = 1.23 (1.02-1.47), P = 0.02]. On landmark analysis, differences in mortality emerged after the first year and were maintained thereafter. Ischaemic outcomes were comparable between cohorts.
Following ACS, males experienced a greater long-term risk of developing new-onset HF as compared with females. This difference remained consistent across all prespecified subgroups. Mortality was significantly higher in males. No differences were observed in ischaemic outcomes. New-onset HF emerges as a primary contributor to long-term gender disparities after ACS and a strong predictor of mortality in men with HF.
关于经皮冠状动脉介入治疗(PCI)的急性冠状动脉综合征(ACS)患者长期临床结局的性别差异研究较少。在这些患者中,心力衰竭(HF)对长期预后是否有不同影响仍不确定。
我们查询了接受PCI的ACS患者的大规模数据库。主要终点是新发HF。次要终点包括死亡率、心肌梗死、再次PCI和缺血性卒中。生成倾向评分匹配以平衡组间特征。对倾向评分匹配后的3334例患者进行了分析。随访在5年时进行评估。
在5年随访时,男性发生HF的风险显著高于女性{17.9%对14.8%,风险比[HR][95%置信区间(CI)]=1.22[1.03 - 1.44],P = 0.02}。在5年随访时,男性队列的死亡率显著高于女性队列[HR(95%CI)=1.23(1.02 - 1.47),P = 0.02]。在标志性分析中,死亡率差异在第一年之后出现并持续存在。各队列之间的缺血性结局相当。
ACS后,与女性相比,男性发生新发HF的长期风险更高。这种差异在所有预先指定的亚组中均保持一致。男性死亡率显著更高。在缺血性结局方面未观察到差异。新发HF成为ACS后长期性别差异的主要因素以及HF男性患者死亡率的有力预测指标。